Dyrenium
NDC 59212-002, Triamterene, capsule, from Advanz Pharma (US) Corp..
- Product NDC
- 59212-002
- Status
- Listed
- Labeler
- Advanz Pharma (US) Corp.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA013174
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/59212-002 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TRIAMTERENE50 mg/1
Pharmacologic classes
Decreased Renal K+ Excretion [PE]; Increased Diuresis [PE]; Potassium-sparing Diuretic [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 59212-002-01 | 59212000201 | 100 CAPSULE in 1 BOTTLE (59212-002-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/ebb177c0-d45d-4443-a85a-e76bd9931a42
Use it
Look up 59212-002 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/59212-002 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 59212-002. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.